VISTOGARD is a Oral Granule in the Human Prescription Drug category. It is labeled and distributed by Wellstat Therapeutics Corporation. The primary component is Uridine Triacetate.
Product ID | 69468-151_8e64b577-1ecb-46f2-a7c8-3577a16f8837 |
NDC | 69468-151 |
Product Type | Human Prescription Drug |
Proprietary Name | VISTOGARD |
Generic Name | Uridine Triacetate |
Dosage Form | Granule |
Route of Administration | ORAL |
Marketing Start Date | 2016-03-01 |
Marketing Category | NDA / NDA |
Application Number | NDA208159 |
Labeler Name | Wellstat Therapeutics Corporation |
Substance Name | URIDINE TRIACETATE |
Active Ingredient Strength | 951 mg/g |
Pharm Classes | Pyrimidine Analog [EPC],Pyrimidines [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2016-03-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA208159 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2016-03-01 |
Marketing Category | NDA |
Application Number | NDA208159 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2016-03-01 |
Marketing Category | NDA |
Application Number | NDA208159 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2016-03-01 |
Ingredient | Strength |
---|---|
URIDINE TRIACETATE | 951 mg/g |
SPL SET ID: | 5a0ba417-8a4a-4d7f-b85a-1839ee8bd3f1 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
69468-151 | VISTOGARD | uridine triacetate |
69468-152 | XURIDEN | uridine triacetate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VISTOGARD 85386983 4859937 Live/Registered |
Wellstat Therapeutics Corporation 2011-08-02 |